Medirom Healthcare Technologies Stock Z Score

MRM Stock

USD 2.99 0.28 10.33%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Medirom Healthcare Piotroski F Score and Medirom Healthcare Valuation analysis.

At this time, Medirom Healthcare's Capital Lease Obligations is very stable compared to the past year. As of the 26th of November 2024, Change In Working Capital is likely to grow to about 523.7 M, while Capital Stock is likely to drop about 19 M. At this time, Medirom Healthcare's Interest Income is very stable compared to the past year. As of the 26th of November 2024, Net Income From Continuing Ops is likely to grow to about 120.8 M, though Net Interest Income is likely to grow to (34 M).

Medirom Healthcare Technologies Company Z Score Analysis

Medirom Healthcare's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Medirom Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Medirom Healthcare is extremely important. It helps to project a fair market value of Medirom Stock properly, considering its historical fundamentals such as Z Score. Since Medirom Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medirom Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medirom Healthcare's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Total Liab	Net Invested Capital	Long Term Investments	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Deferred Long Term Liab
Total Assets		0.32	-0.71	-0.68	-0.14	-0.25	0.33	0.96	-0.32	0.89	-0.91	0.96	0.85	0.14	-0.33	0.9	0.38	-0.05	-0.6	0.85	0.38	-0.56	-0.58
Total Stockholder Equity	0.32		0.39	0.05	-0.56	0.12	-0.55	0.1	-0.43	0.03	-0.08	0.05	0.7	-0.67	-0.03	0.53	0.22	0.62	-0.3	0.19	0.22	-0.75	-0.23
Net Tangible Assets	-0.71	0.39		0.7	-0.38	0.24	-0.8	-0.8	-0.17	-0.86	0.82	-0.87	-0.32	-0.66	0.19	-0.42	-0.12	0.64	0.35	-0.75	-0.12	0.03	0.49
Current Deferred Revenue	-0.68	0.05	0.7		0.3	0.73	-0.75	-0.7	-0.01	-0.85	0.57	-0.73	-0.27	0.01	0.72	-0.67	-0.71	0.13	0.83	-0.45	-0.71	0.19	0.2
Net Debt	-0.14	-0.56	-0.38	0.3		0.51	0.34	-0.07	0.66	0.01	-0.15	0.01	-0.18	0.9	0.6	-0.53	-0.71	-0.87	0.67	0.23	-0.71	0.45	-0.19
Retained Earnings	-0.25	0.12	0.24	0.73	0.51		-0.47	-0.36	0.01	-0.48	0.0	-0.31	0.09	0.25	0.98	-0.39	-0.94	-0.28	0.56	0.19	-0.94	-0.23	-0.49
Accounts Payable	0.33	-0.55	-0.8	-0.75	0.34	-0.47		0.42	0.57	0.67	-0.43	0.51	-0.13	0.51	-0.37	0.12	0.26	-0.69	-0.33	0.34	0.26	0.31	-0.1
Long Term Debt	0.96	0.1	-0.8	-0.7	-0.07	-0.36	0.42		-0.31	0.9	-0.89	0.99	0.72	0.29	-0.42	0.84	0.41	-0.1	-0.53	0.76	0.41	-0.35	-0.45
Net Receivables	-0.32	-0.43	-0.17	-0.01	0.66	0.01	0.57	-0.31		0.04	0.21	-0.21	-0.41	0.46	0.13	-0.54	-0.21	-0.7	0.4	-0.11	-0.21	0.58	0.22
Good Will	0.89	0.03	-0.86	-0.85	0.01	-0.48	0.67	0.9	0.04		-0.79	0.93	0.59	0.29	-0.48	0.72	0.49	-0.28	-0.58	0.75	0.49	-0.27	-0.4
Short Term Investments	-0.91	-0.08	0.82	0.57	-0.15	0.0	-0.43	-0.89	0.21	-0.79		-0.93	-0.72	-0.41	0.06	-0.73	-0.04	0.35	0.44	-0.91	-0.04	0.45	0.73
Total Liab	0.96	0.05	-0.87	-0.73	0.01	-0.31	0.51	0.99	-0.21	0.93	-0.93		0.7	0.35	-0.35	0.8	0.34	-0.23	-0.55	0.83	0.34	-0.37	-0.54
Net Invested Capital	0.85	0.7	-0.32	-0.27	-0.18	0.09	-0.13	0.72	-0.41	0.59	-0.72	0.7		-0.05	-0.05	0.82	0.16	0.18	-0.35	0.74	0.16	-0.72	-0.58
Long Term Investments	0.14	-0.67	-0.66	0.01	0.9	0.25	0.51	0.29	0.46	0.29	-0.41	0.35	-0.05		0.34	-0.25	-0.49	-0.84	0.46	0.38	-0.49	0.45	-0.22
Short Long Term Debt	-0.33	-0.03	0.19	0.72	0.6	0.98	-0.37	-0.42	0.13	-0.48	0.06	-0.35	-0.05	0.34		-0.52	-0.97	-0.4	0.59	0.16	-0.97	-0.13	-0.46
Total Current Assets	0.9	0.53	-0.42	-0.67	-0.53	-0.39	0.12	0.84	-0.54	0.72	-0.73	0.8	0.82	-0.25	-0.52		0.59	0.32	-0.76	0.6	0.59	-0.64	-0.4
Capital Stock	0.38	0.22	-0.12	-0.71	-0.71	-0.94	0.26	0.41	-0.21	0.49	-0.04	0.34	0.16	-0.49	-0.97	0.59		0.5	-0.68	-0.1	1.0	-0.06	0.37
Net Working Capital	-0.05	0.62	0.64	0.13	-0.87	-0.28	-0.69	-0.1	-0.7	-0.28	0.35	-0.23	0.18	-0.84	-0.4	0.32	0.5		-0.25	-0.42	0.5	-0.31	0.37
Short Term Debt	-0.6	-0.3	0.35	0.83	0.67	0.56	-0.33	-0.53	0.4	-0.58	0.44	-0.55	-0.35	0.46	0.59	-0.76	-0.68	-0.25		-0.39	-0.68	0.59	0.34
Intangible Assets	0.85	0.19	-0.75	-0.45	0.23	0.19	0.34	0.76	-0.11	0.75	-0.91	0.83	0.74	0.38	0.16	0.6	-0.1	-0.42	-0.39		-0.1	-0.61	-0.89
Common Stock	0.38	0.22	-0.12	-0.71	-0.71	-0.94	0.26	0.41	-0.21	0.49	-0.04	0.34	0.16	-0.49	-0.97	0.59	1.0	0.5	-0.68	-0.1		-0.06	0.37
Property Plant Equipment	-0.56	-0.75	0.03	0.19	0.45	-0.23	0.31	-0.35	0.58	-0.27	0.45	-0.37	-0.72	0.45	-0.13	-0.64	-0.06	-0.31	0.59	-0.61	-0.06		0.74
Deferred Long Term Liab	-0.58	-0.23	0.49	0.2	-0.19	-0.49	-0.1	-0.45	0.22	-0.4	0.73	-0.54	-0.58	-0.22	-0.46	-0.4	0.37	0.37	0.34	-0.89	0.37	0.74

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Medirom Healthcare

Based on the company's disclosures, Medirom Healthcare Technologies has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Providers & Services sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Medirom Healthcare Current Valuation Drivers

We derive many important indicators used in calculating different scores of Medirom Healthcare from analyzing Medirom Healthcare's financial statements. These drivers represent accounts that assess Medirom Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Medirom Healthcare's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	7.0B	6.0B	3.4B	3.2B	4.2B	5.8B
Enterprise Value	8.2B	6.4B	5.1B	5.1B	7.7B	7.7B

Medirom Healthcare ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medirom Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medirom Healthcare's managers, analysts, and investors.

Environmental

Governance

Social

Medirom Healthcare Institutional Holders

Institutional Holdings refers to the ownership stake in Medirom Healthcare that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medirom Healthcare's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medirom Healthcare's value.

		Shares
Ubs Group Ag	2024-06-30	30.0
Bank Of America Corp	2024-06-30	25.0

Medirom Fundamentals

	Return On Equity	1.47
	Return On Asset	-0.036
	Profit Margin	0.02 %
	Operating Margin	(0.02) %
	Current Valuation	37.28 M
	Shares Outstanding	5.04 M
	Shares Owned By Insiders	40.37 %
	Number Of Shares Shorted	40.95 K
	Price To Book	13.24 X
	Price To Sales	0 X
	Revenue	6.83 B
	Gross Profit	1.42 B
	EBITDA	(138.98 M)
	Net Income	115.05 M
	Cash And Equivalents	354.95 M
	Cash Per Share	72.70 X
	Total Debt	3.65 B
	Current Ratio	0.36 X
	Book Value Per Share	43.19 X
	Cash Flow From Operations	(631.74 M)
	Short Ratio	0.71 X
	Earnings Per Share	(0.15) X
	Number Of Employees	390
	Beta	0.009
	Market Capitalization	15.08 M
	Total Asset	6.85 B
	Retained Earnings	80.28 M
	Working Capital	(1.8 B)
	Net Asset	6.85 B

About Medirom Healthcare Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medirom Healthcare Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medirom Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medirom Healthcare Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:

How To Invest In Medirom

Details

Is Medirom Stock a good investment?

Details

What is Medirom Healthcare's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Medirom Healthcare Piotroski F Score and Medirom Healthcare Valuation analysis.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.582

Earnings Share

(0.15)

Revenue Per Share

1.4 K

Quarterly Revenue Growth

(0.06)

Return On Assets

(0.04)

The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medirom Healthcare Technologies Stock Z Score

Medirom Healthcare Technologies Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Medirom Z Score Driver Correlations

Medirom Healthcare Current Valuation Drivers

Medirom Healthcare ESG Sustainability

Medirom Healthcare Institutional Holders

Medirom Fundamentals

About Medirom Healthcare Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY